Logotype for Canadian Solar Inc

Canadian Solar (CSIQ) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Canadian Solar Inc

Q4 2025 earnings summary

19 Mar, 2026

Executive summary

  • 2025 was marked by persistent market headwinds and regulatory shifts, prompting a strategic pivot toward margin protection and high-value markets, especially in the U.S.

  • Delivered 24.3 GW of solar modules and 7.8 GWh of energy storage globally in 2025, with record U.S. shipments and a $3.6 billion contracted storage backlog.

  • Net loss attributable to shareholders was $104 million for the year, or $2.5 per diluted share.

  • Strategic U.S. manufacturing expansion underway, including new CS PowerTech platform, Texas and Indiana capacity increases, and Kentucky facility plans.

  • Resumed direct oversight of U.S. operations, forming CS PowerTech as the new U.S. manufacturing platform.

Financial highlights

  • 2025 total revenue was $5.6 billion, impacted by lower solar and storage volumes and lighter project sales.

  • Q4 2025 revenue was $1.2 billion, with a net loss attributable to shareholders of $86 million and a diluted loss per share of $1.66.

  • Gross margin for Q4 2025 was 10.2%, down sequentially and year-over-year.

  • Full-year gross profit was $1.03 billion with operating expenses of $983 million.

  • Ended 2025 with $1.9 billion in cash and $6.5 billion in total debt, including $2.2 billion non-recourse debt under Recurrent Energy.

Outlook and guidance

  • Q1 2026 guidance: solar module shipments of 2.2–2.4 GW, energy storage shipments of 1.7–1.9 GWh, revenue of $900M–$1.1B, gross margin 13%–15%.

  • Full-year 2026 U.S. guidance: 6.5–7 GW module shipments, 4.5–5.5 GWh storage shipments; U.S. module shipments expected to be slightly lower due to supply constraints.

  • 2026 is positioned as a transition year, focusing on U.S. manufacturing expansion and profitability diversification.

  • U.S. solar module manufacturing is constrained in the near term by compliant cell supply, expected to improve as domestic capacity scales.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more